Диссертация (1140393), страница 21
Текст из файла (страница 21)
V. 24(4). P. 175-184.178. Altered peptidase activities in thyroid neoplasia and hyperplasia / LarrinagaG., Blanco L., Errarte P., Beitia M., Sanz B., Perez I., Irazusta A., SánchezC.E., Santaolalla F., Andrés L., López J.I. // Dis Markers. 2013. V. 35(6). P.825-832.179. Anaplastic thyroid cancer: ultrasonographic findings and the role of ultrasonography-guided fine needle aspiration biopsy / Suh H.J., Moon H.J., KwakJ.Y., Choi J.S., Kim E.K. // Yonsei Med J. 2013. V.
54(6). P. 1400-1406.180. Bartolazzi A., Sciacchitano S., D'Alessandria C. Galectin-3: the impact onthe clinical management of patients with thyroid nodules and future perspectives // Int J Mol Sci. 2018. V. 19(2). P. 445.181. Biochemical effects of levothyroxine withdrawal in patients with differentiated thyroid cancer / Papadakis G., Kalaitzidou S., Triantafillou E [et al.] //Anticancer Res. 2015 V. 35(12). P. 6933-6940.146182. Bongiovanni M., Trimboli P., Rossi E.D. High-yield thyroid fine-needle aspiration cytology: an update focused on ancillary techniques improving itsaccuracy // European Journal of Endocrinology. 2016.
V. 174. P. 53-63.183. Burman K.D., Wartofsky L. Thyroid Nodules // N Engl J Med. 2015. V.373(24). P. 2347-2356.184. Cătană R., Boilă A., Borda A. Thyroid cancer profile in Mures County (Romania): a 20 years study // Rom J Morphol Embryol. 2012. V. 53(4). P.1007-1012.185. CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroidcarcinoma and nodular thyroid lesions / Erdogan-Durmus S., Ozcan D., Yarikkaya E., Kurt A., Arslan A.
// J Res Med Sci. 2016. V. 21. P. 49.186. Clinical characteristics of thyroid abnormalities induced by sunitinib treatment in Japanese patients with renal cell carcinoma / Sato S., Muraishi K.,Tani J. [et al.] // Endocr J. 2010. V. 57(10). P. 873-880.187. Combination of galectin-3, CK19 and HBME-1 immunostaining improvesthe diagnosis of thyroid cancer / Arcolia V., Journe F., Renaud F., LeteurtreE., Gabius H.J., Remmelink M., Saussez S. // Oncol Lett. 2017. V. 4. P.4183-4189.188.
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma / Bose D., Das R.N., Chatterjee U., Banerjee U. // Indian J Med Paediatr Oncol. 2012. V. 33(2). P. 107-111.189. Diagnostic accuracy of contrast-enhanced ultrasound enhancement patternsfor thyroid nodules / Zhang Y., Luo Y.K., Zhang M.B., Li J., Tang J. // MedSci Monit. 2016. V. 22. P. 4755-4764.190. Differentiating benign from malignant thyroid nodules: comparison of 2and 3- dimensional sonography / Jang M., Kim S.M., Lyou C.Y. [et al.] // JUltrasound Med. 2012. V. 31(2). P. 197-204.191. Effect of 3`UTR RET variants on RET mRNA secondary structure and disease presentation in medullary thyroid carcinoma / Ceolin L., Romitt M.
[etal.] // PLOS ONE. 2016. P. 1-15.147192. Expression of cytokeratin-19 (CK19) in the classical subtype of papillarythyroid carcinoma: the experience of one center in the Silesian region Kaliszewski K., Diakowska D., Strutynska-Karpinska M., Rzeszutko M., Grzegrzolka J., Dziegiel P., Wojtczak B., Sutkowski K. // Folia Histochem Cytobiol. 2016. V. 54(4). P.
193-201.193. Fine-needle aspiration cytology of metastatic squamous cell carcinoma thyroid: A rare entity / Kundu R., Punia R.S., Mohan H., Handa U., Gupta N. //J Cytol. 2014. V. 31(4). P. 210-212.194. Follicular adenoma with extensive extracellular mucin deposition: report ontwo cases / Kim N.R., Cho H.Y., Piña-Oviedo S., De La Roza G., Lee Y.D.,Ro J.Y. // Clin Med Insights Case Rep. 2012.
V. 5. P. 155-162.195. Galectin-1 is a diagnostic marker involved in thyroid cancer progression /Arcolia V., Journe F., Wattier A., Leteurtre E., Renaud F., Gabius H.J.,Remmelink M., Decaestecker C., Rodriguez A., Boutry S., Laurent S.,Saussez S. // Int J Oncol. 2017. V. 3.
P. 760-770.196. Galectin-3 and HBME-1 expression on agarose cell blocks from fine-needleaspirates of follicular cell-derived thyroid tumors / Abu-Sinna E., HasanM.Y., El-Deftar M.M., Amer S.A., Abdelsalam L.O., Nakhla J.A. // J Cytol.2018. V. 35(1). P. 7-32.197. Galectin-3 performance in histologic a cytologic assessment of thyroid nodules: a systematic review and meta-analysis / Trimboli P., Virili C.,Romanelli F., Crescenzi A., Giovanella L. // Int J Mol Sci. 2017. V. 18(8).
P.E1756.198. Gietka-Czernel M. The thyroid gland in postmenopausal women: physiologyand diseases // Prz Menopauzalny. 2017. V. 2. P. 33-37.199. Giovanella L., Imperiali M., Trimboli P. Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiatedthyroid cancer. // Sci Rep. 2017. V. 7(1). P.
7359.148200. Girardi F.M., Barra M.B., Zettler C.G. Variants of papillary thyroid carcinoma: association with histopathological prognostic factors // Braz J Otorhinolaryngol. 2013. V. 79(6). Р. 738-744.201. Hartmann K. Thyroid disorders in the oncology patient // J Adv Pract Oncol.2015. V. 6(2). P.
99-106.202. HBME-1 expression in differentiated thyroid carcinoma and its correlationwith the ultrasonic manifestation of thyroid / Qiao J., Li C., Zhang Y., WangS., Gao S. // Oncol Lett. 2017. V. 14(6). P. 6505-6510.203. Hemithyroidectomy is the preferred initial operative approach for an indeterminate fine needle aspiration biopsy diagnosis / Chiu C.G., Yao R., ChanS.K. [et al.] // Can J Surg. 2012. V. 55(3). P. 191-198.204. Histological and immunohistochemical aspects of papillary thyroid cancer /Radu T.G., Mogoanta L. [et al.] // Rom J Morphol Embryol. 2015.
V. 56. P.789–795.205. Hyalinizing trabecular tumor of the thyroid: diagnosis of a rare tumor usingultrasonography, cytology, and intraoperative frozen sections / Jang H., ParkC.K., Son E.J. [et al.] // Ultrasonography. 2015. V. 4. P. 150-154.206. Identification of thyroid tumor cell vulnerabilities through a siRNA-basedfunctional screening / Anania M.C., Gasparri F. [et al.] // Oncotarget. 2015.V. 6. P.
34629-34648.207. Identification, characterization, and targeting of IL-4 receptor by IL-4Pseudomonas exotoxin in mouse models of anaplastic thyroid cancer / JoshiB.H., Suzuki A., Fujisawa T. [et al.] // Discov Med. 2015. V. 20(111). P.273-284.208. Inter-observer variation in ultrasound measurement of the volume and diameter of thyroid nodules / Choi Y.J., Baek J.H., Hong M.J., Lee J.H. // KoreanJ Radiol. 2015. V. 16 (3). P.
560-565.209. Intercellular adhesion molecule 1 is a sensitive and diagnostically usefulimmunohistochemical marker of papillary thyroid cancer (PTC) and of PTClike nuclear alterations in Hashimoto's thyroiditis / Zhang K.E., Ge S.J., Lin149X.Y., Ly B.B., Cao Z.X., Li J.M., Xu J.W., Wang Q.X. // Oncol Lett. 2016.V.
3. P. 1722-1730.210. Interobserver and intraobserver variability in the sonographic measurementof the size of the thyroid gland by extended field-of-view sonography / Turgut A.T., Coskun Z.U. [et al.] // Journal of Diagnostic Medical Sonography.2008. V. 24. P. 147-152.211. Katović S.K., Vasilj A. Preoperative diagnostics of thyroid medullary carcinoma with emphasis on cytomorphological features and differential diagnosis of primary and secondary thyroid tumors // Acta Med Croatica. 2014.
V.68. P. 383-388.212. Kim J., Bang Y., Lee W.J. Living near nuclear power plants and thyroidcancer risk: A systematic review and meta-analysis // Environ Int. 2015. V.2. P. 42-48.213. Kinase inhibitors for advanced medullary thyroid carcinoma / SchlumbergerM., Massicotte M.H., Nascimento C.L., Chougnet C., Baudin E., LeboulleuxS. // Clinics (San Paulo). 2012. V. 67. P.
125-129.214. Makay Ö. Less than total thyroidectomy for goiter: when and how? // GlandSurg. 2017. V. 1 P. 49-58.215. Mazzaferri E.L. Managing thyroid microcarcinomas // Yonsei Med J. 2012.V. 53(1). P. 1-14.216. Mikhaĭlova M.V., Zubarovskiĭ I.N., Osipenko S.K. Diagnostic and treatmentstrategy in follicular tumor of thyroid gland. // Vestn Khir Im I I Grek.
2015.V. 174(2). P. 77-80.217. Molecular basis of medullary thyroid carcinoma: the role of RET polymorphisms / Ceolin L., Siqueira D.R., Romitti M., Ferreira C.V., Maia A.L. //Int J Mol Sci. 2012. V. 13(1). P. 221-239.218. Morphological changes of follicular cell basal borders and basement membranes in benign and malignant nodular lesions of the thyroid gland: an ultrastructural study / Cavallari V., Albiero F., Cicciarello R. [et al.] // Ultrastructural Pathology.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
